Quarterly report · Q2
4530.TEDINET S100RZFF
Period2023-03-01 → 2023-08-31
Filed2023-10-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 49
| Metric | Value | Period | Scope | Source row |
|---|---|---|---|---|
| Revenue | ¥67.0bn | 2023-03-01 → 2023-08-31 | Cons. | Net sales |
| Revenue | ¥128.3bn | 2022-03-01 → 2023-02-28 | Cons. | Net sales (5-year summary) |
| Revenue | ¥59.6bn | 2022-03-01 → 2022-08-31 | Cons. | Net sales |
| Operating income | ¥8.4bn | 2023-03-01 → 2023-08-31 | Cons. | Operating income |
| Operating income | ¥4.9bn | 2022-03-01 → 2022-08-31 | Cons. | Operating income |
| Ordinary income | ¥11.6bn | 2023-03-01 → 2023-08-31 | Cons. | Ordinary income |
| Ordinary income | ¥16.1bn | 2022-03-01 → 2023-02-28 | Cons. | Ordinary income loss (5-year summary) |
| Ordinary income | ¥8.9bn | 2022-03-01 → 2022-08-31 | Cons. | Ordinary income |
| Profit before tax | ¥11.6bn | 2023-03-01 → 2023-08-31 | Cons. | Income before income taxes |
| Profit before tax | ¥8.9bn | 2022-03-01 → 2022-08-31 | Cons. | Income before income taxes |
| Net income (owners) | ¥8.4bn | 2023-03-01 → 2023-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income (owners) | ¥11.7bn | 2022-03-01 → 2023-02-28 | Cons. | Profit loss attributable to owners of parent (5-year summary) |
| Net income (owners) | ¥6.5bn | 2022-03-01 → 2022-08-31 | Cons. | Profit loss attributable to owners of parent |
| Net income | ¥8.7bn | 2023-03-01 → 2023-08-31 | Cons. | Profit loss |
| Net income | ¥6.7bn | 2022-03-01 → 2022-08-31 | Cons. | Profit loss |
| Total assets | ¥344.3bn | at 2023-08-31 | Cons. | Assets |
| Total assets | ¥313.9bn | at 2023-02-28 | Cons. | Assets |
| Total assets | ¥327.9bn | at 2022-08-31 | Cons. | Total assets (5-year summary) |
| Total liabilities | ¥69.2bn | at 2023-08-31 | Cons. | Liabilities |
| Total liabilities | ¥55.5bn | at 2023-02-28 | Cons. | Liabilities |
| Net assets / equity | ¥275.1bn | at 2023-08-31 | Cons. | Net assets |
| Net assets / equity | ¥258.4bn | at 2023-02-28 | Cons. | Net assets |
| Net assets / equity | ¥266.3bn | at 2022-08-31 | Cons. | Net assets (5-year summary) |
| Cash and deposits | ¥127.0bn | at 2023-08-31 | Cons. | Cash and deposits |
| Cash and deposits | ¥122.2bn | at 2023-02-28 | Cons. | Cash and deposits |
| Cash & equivalents | ¥81.2bn | at 2023-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥65.4bn | at 2023-02-28 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥78.8bn | at 2022-08-31 | Cons. | Cash and cash equivalents |
| Cash & equivalents | ¥86.2bn | at 2022-02-28d | Cons. | Cash and cash equivalents |
| Operating cash flow | ¥7.9bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in operating activities |
| Operating cash flow | ¥12.7bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in operating activities (5-year summary) |
| Operating cash flow | ¥8.2bn | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in operating activities |
| Investing cash flow | ¥10.4bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in investment activities |
| Investing cash flow | −¥23.9bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in investing activities (5-year summary) |
| Investing cash flow | −¥17.9bn | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in investment activities |
| Financing cash flow | −¥4.8bn | 2023-03-01 → 2023-08-31 | Cons. | Net cash provided by used in financing activities |
| Financing cash flow | −¥14.7bn | 2022-03-01 → 2023-02-28 | Cons. | Net cash provided by used in financing activities (5-year summary) |
| Financing cash flow | −¥3.6bn | 2022-03-01 → 2022-08-31 | Cons. | Net cash provided by used in financing activities |
| EPS (basic) | ¥108.34 | 2023-03-01 → 2023-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥56.25 | 2023-06-01 → 2023-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥148.01 | 2022-03-01 → 2023-02-28 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥81.58 | 2022-03-01 → 2022-08-31 | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (basic) | ¥61.11 | 2022-06-01 → 2022-08-31d | Cons. | Basic earnings loss per share (5-year summary) |
| EPS (diluted) | ¥108.23 | 2023-03-01 → 2023-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥147.88 | 2022-03-01 → 2023-02-28 | Cons. | Diluted earnings per share (5-year summary) |
| EPS (diluted) | ¥81.51 | 2022-03-01 → 2022-08-31 | Cons. | Diluted earnings per share (5-year summary) |
| Equity ratio | 79.2% | at 2023-08-31 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 81.6% | at 2023-02-28 | Cons. | Equity to asset ratio (5-year summary) |
| Equity ratio | 80.5% | at 2022-08-31 | Cons. | Equity to asset ratio (5-year summary) |
Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.
All source rows · 453
| Item | Context | Value | Unit |
|---|---|---|---|
| Purchase of intangible assets inv cf | CurrentYTDDuration | -4000000 | JPY |
| Purchase of investment securities inv cf | Prior1YTDDuration | -5507000000 | JPY |
| Purchase of investment securities inv cf | CurrentYTDDuration | -8000000 | JPY |
| Proceeds from sales of investment securities inv cf | Prior1YTDDuration | 30000000 | JPY |
| Proceeds from sales of investment securities inv cf | CurrentYTDDuration | － | JPY |
| Proceeds from cancellation of insurance funds inv cf | Prior1YTDDuration | － | JPY |
| Proceeds from cancellation of insurance funds inv cf | CurrentYTDDuration | 27000000 | JPY |
| Other net inv cf | Prior1YTDDuration | 346000000 | JPY |
| Other net inv cf | CurrentYTDDuration | 1000000 | JPY |
| Net cash provided by used in investment activities | Prior1YTDDuration | -17928000000 | JPY |
| Net cash provided by used in investment activities | CurrentYTDDuration | 10443000000 | JPY |
| Increase decrease in short term loans payable fin cf | Prior1YTDDuration | － | JPY |
| Increase decrease in short term loans payable fin cf | CurrentYTDDuration | -2000000 | JPY |
| Repayment of long term loans payable fin cf | Prior1YTDDuration | -35000000 | JPY |
| Repayment of long term loans payable fin cf | CurrentYTDDuration | -33000000 | JPY |
| Purchase of treasury stock fin cf | Prior1YTDDuration | -0 | JPY |
| Purchase of treasury stock fin cf | CurrentYTDDuration | -1336000000 | JPY |
| Cash dividends paid fin cf | Prior1YTDDuration | -3357000000 | JPY |
| Cash dividends paid fin cf | CurrentYTDDuration | -3287000000 | JPY |
| Dividends paid to non controlling interests fin cf | Prior1YTDDuration | -61000000 | JPY |
| Dividends paid to non controlling interests fin cf | CurrentYTDDuration | -108000000 | JPY |
| Other net fin cf | Prior1YTDDuration | -185000000 | JPY |
| Other net fin cf | CurrentYTDDuration | -73000000 | JPY |
| Net cash provided by used in financing activities | Prior1YTDDuration | -3641000000 | JPY |
| Net cash provided by used in financing activities | CurrentYTDDuration | -4841000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | Prior1YTDDuration | 5932000000 | JPY |
| Effect of exchange rate change on cash and cash equivalents | CurrentYTDDuration | 2307000000 | JPY |
| Net increase decrease in cash and cash equivalents | Prior1YTDDuration | -7475000000 | JPY |
| Net increase decrease in cash and cash equivalents | CurrentYTDDuration | 15761000000 | JPY |
| Cash and cash equivalents | Prior2YearInstant | 86247000000 | JPY |
| Cash and cash equivalents | Prior1YearInstant | 65424000000 | JPY |
| Cash and cash equivalents | Prior1QuarterInstant | 78771000000 | JPY |
| Cash and cash equivalents | CurrentQuarterInstant | 81186000000 | JPY |
| Advertising expenses sga | Prior1YTDDuration | 5573000000 | JPY |
| Advertising expenses sga | CurrentYTDDuration | 6823000000 | JPY |
| Promotion expenses sga | Prior1YTDDuration | 5396000000 | JPY |
| Promotion expenses sga | CurrentYTDDuration | 5761000000 | JPY |
| Research and development expenses sga | Prior1YTDDuration | 4935000000 | JPY |
| Research and development expenses sga | CurrentYTDDuration | 4140000000 | JPY |
| Document title cover page | FilingDateInstant | Original text (Japanese)四半期報告書 | |
| Clause of stipulation cover page | FilingDateInstant | Original text (Japanese)金融商品取引法第24条の４の７第１項 | |
| Place of filing cover page | FilingDateInstant | Original text (Japanese)関東財務局長 | |
| Filing date cover page | FilingDateInstant | 2023-10-10 | |
| Quarterly accounting period cover page | FilingDateInstant | Original text (Japanese)第122期第２四半期(自 2023年６月１日 至 2023年８月31日) | |
| Company name cover page | FilingDateInstant | Original text (Japanese)久光製薬株式会社 | |
| Company name in english cover page | FilingDateInstant | HISAMITSU PHARMACEUTICAL CO.,INC. | |
| Title and name of representative cover page | FilingDateInstant | Original text (Japanese)代表取締役社長 中 冨 一 榮 | |
| Address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)佐賀県鳥栖市田代大官町408番地 | |
| Telephone number address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)0942(83)2101(代表) | |
| Name of contact person address of registered headquarter cover page | FilingDateInstant | Original text (Japanese)執行役員BU本部長 舛 屋 泰 之 |
Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.
Data checks · 14 of 14 passed
| balance sheet identity | pass |
| balance sheet identity | pass |
| dei present | pass |
| period resolution | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net assets | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · net income attributable to parent | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · operating cash flow | pass |
| statement vs summary · revenue | pass |
| statement vs summary · revenue | pass |
| statement vs summary · total assets | pass |
| statement vs summary · total assets | pass |